Paid Clinical Trials in Omaha, NE
As of June 2026, 628 paid clinical trials are recruiting in Omaha, Nebraska. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Omaha offers studies at sites including University of Nebraska Medical Center for conditions such as Breast Cancer, Multiple Myeloma, Prostate Cancer, Heart Failure. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Omaha
Filter results
0 clinical trials
·Clear filters·↓ Download CSVAbout research studies in Omaha
Omaha has approximately 628 recruiting research studies across a wide range of therapeutic areas. Nebraska hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Omaha
Researchers run research studies in Omaha, NE at 50 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Nebraska Medical Center | Acute Myeloid Leukemia, Heart Failure, Multiple Myeloma | 235 |
| Alegent Health Bergan Mercy Medical Center | Breast Cancer, Stage IIIB Lung Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | 43 |
| Nebraska Medicine-Village Pointe | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8 | 40 |
| Creighton University Medical Center | Stage IIIB Lung Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 38 |
| Nebraska Cancer Specialists | Breast Cancer, Colorectal Cancer, Endometrial Cancer | 38 |
| Alegent Health Immanuel Medical Center | Stage IIIB Lung Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 37 |
| Alegent Health Lakeside Hospital | Stage IIIB Lung Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 37 |
| Nebraska Methodist Hospital | Endometrial Cancer, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma | 33 |
| Children's Hospital and Medical Center of Omaha | B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm, Acute Myeloid Leukemia | 29 |
| Nebraska Cancer Specialists/Oncology Hematology West PC - MECC | Metastatic Nasopharyngeal Carcinoma, Ovarian Carcinoma, Recurrent Nasopharyngeal Carcinoma | 20 |
| Oncology Associates PC | Metastatic Nasopharyngeal Carcinoma, Ovarian Carcinoma, Recurrent Nasopharyngeal Carcinoma | 16 |
| Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE | Chronic Obstructive Pulmonary Disease, Adult Growth Hormone Deficiency, Alcohol Use Disorder (AUD) | 13 |
| University of Nebraska | Adenocarcinoma, Pancreatic Ductal, Adenovirus Infections, Brain Tumor | 11 |
| Oncology Hematology West P.C. dba Nebraska Cancer Specialists | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) | 8 |
| Children's Nebraska | Acute Kidney Injury, Acute Respiratory Distress Syndrome, Bronchiolitis Acute | 7 |
| Nebraska Medical Center | Atrial Fibrillation, Cardiac Arrest, Cardiopulmonary Arrest | 7 |
| Boys Town National Research Hospital | Developmental Language Disorder, Autism, Autism Spectrum Disorder | 6 |
| Creighton University | Age-associated Muscle Loss, Bilateral Vestibular Hypofunction, Empyema, Pleural | 6 |
| Nebraska Medicine | Cachexia, Choline Deficiency, Engagement | 6 |
| Oncology Hematology West, PC DBA Nebraska Cancer Specialists | Carcinoma, Non-Small-Cell Lung, Follicular Lymphoma (FL), Metastatic Castration Resistant Prostate Cancer (mCRPC) | 6 |
| Nebraska Cancer Specialists - Omaha - Wright Street | Gastric/Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, High-Grade Serous Ovarian Cancer | 6 |
| GSK Investigational Site | Colonic Neoplasms, Gastrointestinal Neoplasms, HIV Infections | 5 |
| Children's Hospital & Medical Center | Acute Treatment of Migraine, COVID-19, Chronic Hepatitis B | 5 |
| Hematology and Oncology Consultants PC | Anatomic Stage IV Breast Cancer AJCC v8, Cardiotoxicity, Childhood Extracranial Germ Cell Tumor | 5 |
| Skin Specialists, PC dba Schlessinger MD | Severe Alopecia Areata, Atopic Dermatitis, Hidradenitis Suppurativa | 4 |
| Unversity of Nebraska Medical Center | Chronic Pancreatitis, Diabetes Mellitus, Type 2, Genetic Predisposition to Disease | 4 |
| Velocity Clinical Research, Omaha | COVID-19 SARS-CoV-2 Infection, Clostridioides Difficile Associated Disease, Cortisol Excess | 4 |
| Fred & Pamela Buffet Cancer Center | Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT), Diffuse Large B-Cell Lymphoma, Prostate Adenocarcinoma | 3 |
| Vance Thompson Vision | Age-Related Macular Degeneration, Astigmatism, Geographic Atrophy | 3 |
| XCancer | Castration-Resistant Prostate Cancer (CRPC), Cervical Cancer, Colorectal Cancer | 3 |
| XCancer Omaha / Urology Cancer Center | Breast Cancer, Cervical Cancer, Colon Cancer | 3 |
| Adult & Pediatric Urology | Benign Prostatic Hyperplasia (BPH), Overactive Bladder (OAB) | 2 |
| Children's Hospital and Medical Center | Anesthesia, Children, Failed or Difficult Intubation, Sequela | 2 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 2 |
| Lied Transplant Center at Nebraska Medical Center | Short Bowel Syndrome, Short Bowel Syndrome (SBS) | 2 |
| Methodist Physicians Clinic | Acute Myocardial Infarction (AMI), COPD Exacerbation, Cardiovascular Risk | 2 |
| Methodist Women's Hospital | Eclampsia Preeclampsia, Hypertension in Pregnancy, Severe Preeclampsia | 2 |
| Nebraska Cancer Specialists - Midwest Cancer Center - Legacy | Advanced Non-Small Cell Lung Cancer, Cancer Harboring BRAF Alterations, HGG | 2 |
| Nebraska Cancer Specialists - Omaha | Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma | 2 |
| Nebraska Medicine - Village Pointe | Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma, Non-Small Cell Lung Cancer Metastatic | 2 |
| Omaha VA Medical Center | Cardiovascular Diseases, Cognitive Impairment, Mild, Dementia | 2 |
| Oncology Hematology West PC | Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma | 2 |
| Oncology Hematology West PC dba Nebraska Cancer Specialists | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer | 2 |
| Oncology Hematology West, PC dba Nebraska Cancer Specialists - Legacy | Breast Cancer, Multiple Myeloma | 2 |
| Quality Clinical Research Inc | Diabetes, Type 2, Obesity, Obesity and Overweight | 2 |
| Quality Clinical Research, Merz Investigational | Chronic Migraine, Episodic Migraine | 2 |
| Quality Living, Inc. | Brain Injuries, Traumatic, Spinal Cord Injury Cervical | 2 |
| Research Facility | Carcinoid, Carcinoid Tumor, GEP-NET | 2 |
| Skin Specialists | Dermatitis Atopic | 2 |
| TG Therapeutics Investigational Trial Site | B-cell Mediated Autoimmune Disorders, Multiple Sclerosis, Relapsing Multiple Sclerosis | 2 |
Active & Upcoming Studies in Omaha (2026)
Recruiting trials in Omaha grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (277 active studies)
- Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer · Phase 3 · Pfizer
- Whole Versus Partial Gland Boost During Prostate SBRT · Phase 2, Phase 3 · University of Nebraska
Cardiovascular (42 active studies)
- Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest · Phase 3 · Invero Pharma, Inc.
- Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids · Phase 1, Phase 2 · University of Nebraska
Diabetes & metabolic (18 active studies)
Neurology & pain (16 active studies)
- Attention and Eye Movement in Parkinson's Disease · University of Nebraska
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine · Phase 3 · Merz Therapeutics GmbH
Vaccines (11 active studies)
- A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults · Phase 3 · ModernaTX, Inc.
- A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza · Phase 3 · Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Pediatric (9 active studies)
- Evaluating the Effects of an Electrical Stimulator on Improving the Walking Ability of Children With Cerebral Palsy · University of Nebraska
- iAmHealthy Clinical Practice Guideline (CPG) · University of Kansas Medical Center
Mental health & behavior (5 active studies)
- Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU) · Bristol-Myers Squibb
- A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor · Phase 4 · Neurocrine Biosciences
Eye & vision (5 active studies)
HIV / STI (2 active studies)
- A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) · Phase 2 · ViiV Healthcare
- Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection · Phase 2 · Gilead Sciences
Common conditions studied in Omaha
- Breast Cancer (17 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Multiple Myeloma (15 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Prostate Cancer (14 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
- Heart Failure (12 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Ovarian Cancer (10 active studies). Ovarian cancer research examines PARP inhibitors, maintenance therapies, and antibody-drug conjugates for recurrent and platinum-resistant disease.
- Endometrial Cancer (9 active studies). Recruiting Endometrial Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Omaha
- University of Nebraska
- National Cancer Institute (NCI)
- AstraZeneca
- SWOG Cancer Research Network
- Pfizer
Local regulations and guidelines
Clinical trials in Nebraska are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Nebraska research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Omaha. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Omaha
Hipa.ai aggregates every recruiting study in Omaha from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Omaha?
There are approximately 628 recruiting clinical trials in Omaha, Nebraska listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Omaha pay participants?
Most recruiting trials in Omaha compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Omaha?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Omaha?
The most common conditions under active study in Omaha include Breast Cancer (17), Multiple Myeloma (15), Prostate Cancer (14), Heart Failure (12), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Omaha?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Omaha on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Omaha?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Omaha?
Recruiting research sites in Omaha include University of Nebraska Medical Center, Alegent Health Bergan Mercy Medical Center, Nebraska Medicine-Village Pointe, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Omaha right now?
The largest active categories in Omaha are Cancer & tumors (277), Cardiovascular (42), Diabetes & metabolic (18). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.